Ryan MacDonald
Stock Analyst at Needham
(0.04)
# 4,702
Out of 4,974 analysts
614
Total ratings
38%
Success rate
-11.6%
Average return
Main Sectors:
Stocks Rated by Ryan MacDonald
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OMDA Omada Health | Reiterated: Buy | $28 | $19.67 | +42.35% | 8 | Sep 11, 2026 | |
| BNED Barnes & Noble Education | Reiterated: Buy | $16 | $10.77 | +48.56% | 28 | Sep 9, 2026 | |
| ODD Oddity Tech | Reiterated: Hold | n/a | $17.95 | - | 5 | Sep 9, 2026 | |
| PHR Phreesia | Reiterated: Buy | $14 | $10.35 | +35.27% | 34 | Sep 3, 2026 | |
| DH Definitive Healthcare | Reiterated: Hold | n/a | $1.00 | - | 24 | Sep 2, 2026 | |
| VEEV Veeva Systems | Reiterated: Buy | $270 → $310 | $266.62 | +16.27% | 33 | Aug 27, 2026 | |
| WAY Waystar Holding | Reiterated: Buy | $33 | $26.67 | +23.73% | 5 | Aug 26, 2026 | |
| DCGO DocGo | Reiterated: Buy | $3 | $0.3849 | +679.42% | 32 | Aug 18, 2026 | |
| MH McGraw Hill | Reiterated: Buy | $19 | $13.25 | +43.40% | 9 | Aug 13, 2026 | |
| HIMS Hims & Hers Health | Reiterated: Buy | $35 → $42 | $27.85 | +50.81% | 16 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $41 | $25.81 | +58.85% | 5 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $8.80 | +240.91% | 26 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $43.00 | $34.06 | +26.24% | 22 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.7424 | - | 51 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $145 | $153.92 | -5.80% | 22 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $13.67 | - | 24 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $76 → $97 | $92.39 | +4.99% | 8 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 | $68.85 | +8.93% | 17 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $5.28 | +89.39% | 37 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $6.58 | - | 23 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $6.39 | +56.49% | 30 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $43 → $25 | $31.04 | n/a | 32 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $226.76 | n/a | 22 | Nov 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $88 → $83 | $67.66 | n/a | 2 | Jun 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $84 → $92 | $260.85 | n/a | 2 | Jun 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $20 | $8.48 | n/a | 9 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $500 | $241.96 | n/a | 18 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $45.08 | n/a | 17 | Jul 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $5.26 | n/a | 12 | Jul 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $46 | $140.35 | n/a | 3 | Jun 22, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $145 → $165 | $257.76 | n/a | 4 | Jun 21, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $78 → $86 | $190.67 | n/a | 5 | Feb 28, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $101 | $255.65 | n/a | 5 | Feb 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $75 | $497.12 | n/a | 5 | Jan 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 → $107 | $141.90 | n/a | 4 | Jan 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $95 → $80 | $137.79 | n/a | 2 | Sep 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 → $30 | $31.23 | n/a | 4 | Sep 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $190 | $375.09 | n/a | 2 | Sep 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $43 | $185.37 | n/a | 1 | Sep 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $7.00 | n/a | 1 | Jul 7, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $5.8 → $3 | $12.57 | n/a | 4 | Dec 26, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $1.5 | $23.26 | n/a | 1 | Mar 6, 2014 |
Omada Health
Sep 11, 2026
Reiterated: Buy
Price Target: $28
Current: $19.67
Upside: +42.35%
Barnes & Noble Education
Sep 9, 2026
Reiterated: Buy
Price Target: $16
Current: $10.77
Upside: +48.56%
Oddity Tech
Sep 9, 2026
Reiterated: Hold
Price Target: n/a
Current: $17.95
Upside: -
Phreesia
Sep 3, 2026
Reiterated: Buy
Price Target: $14
Current: $10.35
Upside: +35.27%
Definitive Healthcare
Sep 2, 2026
Reiterated: Hold
Price Target: n/a
Current: $1.00
Upside: -
Veeva Systems
Aug 27, 2026
Reiterated: Buy
Price Target: $270 → $310
Current: $266.62
Upside: +16.27%
Waystar Holding
Aug 26, 2026
Reiterated: Buy
Price Target: $33
Current: $26.67
Upside: +23.73%
DocGo
Aug 18, 2026
Reiterated: Buy
Price Target: $3
Current: $0.3849
Upside: +679.42%
McGraw Hill
Aug 13, 2026
Reiterated: Buy
Price Target: $19
Current: $13.25
Upside: +43.40%
Hims & Hers Health
Aug 11, 2026
Reiterated: Buy
Price Target: $35 → $42
Current: $27.85
Upside: +50.81%
Aug 7, 2026
Reiterated: Buy
Price Target: $27 → $41
Current: $25.81
Upside: +58.85%
Aug 7, 2026
Reiterated: Buy
Price Target: $30
Current: $8.80
Upside: +240.91%
Aug 7, 2026
Reiterated: Buy
Price Target: $43.00
Current: $34.06
Upside: +26.24%
Aug 6, 2026
Reiterated: Hold
Price Target: n/a
Current: $0.7424
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: $145
Current: $153.92
Upside: -5.80%
Aug 5, 2026
Reiterated: Hold
Price Target: n/a
Current: $13.67
Upside: -
Aug 5, 2026
Reiterated: Buy
Price Target: $76 → $97
Current: $92.39
Upside: +4.99%
Jul 31, 2026
Reiterated: Buy
Price Target: $75
Current: $68.85
Upside: +8.93%
Jul 30, 2026
Reiterated: Buy
Price Target: $10
Current: $5.28
Upside: +89.39%
Jul 30, 2026
Reiterated: Hold
Price Target: n/a
Current: $6.58
Upside: -
Dec 9, 2025
Reiterated: Buy
Price Target: $10
Current: $6.39
Upside: +56.49%
May 2, 2025
Reiterated: Buy
Price Target: $43 → $25
Current: $31.04
Upside: n/a
Nov 1, 2023
Downgraded: Hold
Price Target: n/a
Current: $226.76
Upside: n/a
Jun 20, 2023
Reiterated: Buy
Price Target: $88 → $83
Current: $67.66
Upside: n/a
Jun 20, 2023
Reiterated: Buy
Price Target: $84 → $92
Current: $260.85
Upside: n/a
Feb 28, 2023
Reiterated: Buy
Price Target: $11 → $20
Current: $8.48
Upside: n/a
Nov 3, 2022
Reiterated: Buy
Price Target: $500
Current: $241.96
Upside: n/a
Jul 7, 2021
Rated: Hold
Price Target: n/a
Current: $45.08
Upside: n/a
Jul 7, 2021
Rated: Hold
Price Target: n/a
Current: $5.26
Upside: n/a
Jun 22, 2017
Reiterated: Hold
Price Target: $46
Current: $140.35
Upside: n/a
Jun 21, 2017
Reiterated: Buy
Price Target: $145 → $165
Current: $257.76
Upside: n/a
Feb 28, 2017
Reiterated: Hold
Price Target: $78 → $86
Current: $190.67
Upside: n/a
Feb 27, 2017
Reiterated: Buy
Price Target: $101
Current: $255.65
Upside: n/a
Jan 27, 2017
Reiterated: Buy
Price Target: $70 → $75
Current: $497.12
Upside: n/a
Jan 26, 2017
Reiterated: Buy
Price Target: $95 → $107
Current: $141.90
Upside: n/a
Sep 13, 2016
Downgraded: Hold
Price Target: $95 → $80
Current: $137.79
Upside: n/a
Sep 13, 2016
Initiated Coverage: Buy
Price Target: $23 → $30
Current: $31.23
Upside: n/a
Sep 13, 2016
Initiated Coverage: Buy
Price Target: $190
Current: $375.09
Upside: n/a
Sep 13, 2016
Upgraded: Buy
Price Target: $43
Current: $185.37
Upside: n/a
Jul 7, 2016
Reiterated: Buy
Price Target: $50
Current: $7.00
Upside: n/a
Dec 26, 2014
Upgraded: Hold
Price Target: $5.8 → $3
Current: $12.57
Upside: n/a
Mar 6, 2014
Rated: Buy
Price Target: $1.5
Current: $23.26
Upside: n/a